Zhonggui He

16.4k total citations · 4 hit papers
403 papers, 13.6k citations indexed

About

Zhonggui He is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Zhonggui He has authored 403 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Biomaterials, 166 papers in Biomedical Engineering and 152 papers in Molecular Biology. Recurrent topics in Zhonggui He's work include Nanoparticle-Based Drug Delivery (161 papers), Nanoplatforms for cancer theranostics (152 papers) and RNA Interference and Gene Delivery (49 papers). Zhonggui He is often cited by papers focused on Nanoparticle-Based Drug Delivery (161 papers), Nanoplatforms for cancer theranostics (152 papers) and RNA Interference and Gene Delivery (49 papers). Zhonggui He collaborates with scholars based in China, United States and Japan. Zhonggui He's co-authors include Jin Sun, Cong Luo, Bingjun Sun, Yongjun Wang, Longfa Kou, Xuanbo Zhang, Qiming Kan, Mengchi Sun, Yinglei Zhai and Haotian Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.

In The Last Decade

Zhonggui He

381 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The endocytosis and intracellular fate of nanomedicines: Implication for rational design

2013 470 citations Jin Sun, Zhonggui He et al. profile →
Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy

2018 370 citations Bingjun Sun, Cong Luo et al. profile →
Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy

2022 216 citations Shenwu Zhang, Zhiqiang Kong et al. profile →
Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation

2023 189 citations Kaiyuan Wang, Xia Wang et al. profile →

Peers

Countries citing papers authored by Zhonggui He

Since Specialization

Citations

This map shows the geographic impact of Zhonggui He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonggui He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonggui He more than expected).

Fields of papers citing papers by Zhonggui He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonggui He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonggui He. The network helps show where Zhonggui He may publish in the future.

Co-authorship network of co-authors of Zhonggui He

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonggui He. A scholar is included among the top collaborators of Zhonggui He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonggui He. Zhonggui He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chain architecture-engineered artesunate nanoassemblies target LONP1 to induce oxidative damage for enhanced anti-tumor therapy 2025 ·Chinese Chemical Letters ·(unknown), Xinxin Sun, Jianbin Shi, Zhixiao Zhang, Jin Sun, Cong Luo, Zhonggui He, Shenwu Zhang	0
2	Engineered hydrogel platform for diabetic wound healing 2025 ·Chemical Engineering Journal ·Jie Cui, Jianbin Shi, (unknown), (unknown), Jin Sun, Zhonggui He, Cong Luo, Shenwu Zhang	9
3	Long-acting bioengineered platelets with internal doxorubicin loaded and external quercetin liposomes anchored for post-surgical tumor therapy 2025 ·Journal of Controlled Release ·Qi Lu, (unknown), Xia Wang, (unknown), Xiaoyuan Fan, Jian Zhao, Ruihong Zhu, Helin Wang, Jiaxuan Song, Wenwen Shen, (unknown), Zhonggui He, Kaiyuan Wang, Jin Sun	3
4	Approaches and applications in transdermal and transpulmonary gene drug delivery 2025 ·Frontiers in Bioengineering and Biotechnology ·Anni Zhang, Xuran Zhang, Jiahui Chen, Xianbao Shi, Xijuan Yu, Zhonggui He, Jin Sun, Mengchi Sun, Zhijun Liu	1
5	Phospholipid‐Like Prodrug Liposomes with High Drug‐carrier Affinity and High Tumor Selectivity: Strong Competitors of Paclitaxel Nanomedicines 2025 ·Advanced Functional Materials ·Danping Wang, Shanhui Xu, (unknown), (unknown), (unknown), Yixin Sun, Yaqi Li, Shiyi Zuo, Xiang Gao, Xin Li, Qikun Jiang, Zhonggui He, (unknown), (unknown), An‐Hua Wang, Bingjun Sun	0
6	A molecularly tailored closed-loop tumor cell energy nanodepleter for cancer starvation therapy 2024 ·Nano Today ·Xinxin Sun, Shenwu Zhang, Pengfei Wang, (unknown), (unknown), Qin Chen, Xiaohong Liu, Jin Sun, Zhonggui He, Cong Luo	3
7	AIEgen-functionalized nanoprobes and nanomedicines for cancer diagnosis and therapy 2024 ·Coordination Chemistry Reviews ·Chen Wang, (unknown), (unknown), Jin Sun, Zhonggui He, Yuequan Wang, Shenwu Zhang, Cong Luo	19
8	Cytomembrane-targeted photodynamic priming triggers extracellular vesicle storm for deep penetration and complete destruction of bladder cancer 2024 ·Nano Today ·Xia Wang, Shipeng Ning, Wenhui Tao, Kaiyuan Wang, (unknown), Linghong Huang, Songtao Dong, Zhijin Fan, Judun Zheng, Yang Li, Bin Yang, Zhonggui He, (unknown), Xiaoyuan Chen, Hongxing Liu	10
9	Phytoconstituent-derived nano-medicines/vesicles providing a promising dawn for inflammatory bowel disease 2024 ·Chinese Chemical Letters ·(unknown), Xiaofei Jiang, Miao Wang, (unknown), Zhonggui He, Jin Sun, Huiyuan Gao, Mengchi Sun	5
10	Moisture-induced limited recrystallization may not reduce the dissolution of amorphous solid dispersions: A case of nitrendipine 2024 ·Journal of Industrial and Engineering Chemistry ·(unknown), Hongge Wang, (unknown), Dandan Song, Yang Li, Xing Tang, Zhonggui He, Qiang Fu	6
11	Optimizing the stable doxorubicin prodrug nanocomplex for efficient and selective cancer therapy 2024 ·Chemical Engineering Journal ·(unknown), Jinrui Liu, (unknown), (unknown), Bowen Zhang, Shufang Zheng, Xin Li, Zhonggui He, Xin Wang, Huaiwei Ding, Lingxiao Li, Bingjun Sun	0
12	Dual role of triglyceride structures facilitates anti-tumor drug delivery: Both as a self-assembling module and a responsive module 2024 ·Journal of Colloid and Interface Science ·(unknown), Yalin Xu, Zixuan Wang, Xiyan Wang, Yaqi Li, Jinrui Liu, (unknown), Xianbao Shi, Zhonggui He, Bingjun Sun, (unknown)	2
13	Cascaded multiresponsive supramolecular dimer-engineered nano-modulator enabling spatiotemporally adaptable tumor immune microenvironment remodeling in photodynamic immunotherapy 2024 ·Nano Today ·Yuequan Wang, Pengfei Wang, Wenwen Li, Ziqi Lin, Yuting Wang, Qin Chen, Shenwu Zhang, Zhonggui He, Cong Luo, Jin Sun	4
14	Precisely Self‐Cooperative Nanoassembly Enables Photothermal/Ferroptosis Synergistic Tumor Eradication 2024 ·Advanced Healthcare Materials ·Xiaohong Yang, (unknown), Pengfei Wang, (unknown), Yuequan Wang, Haotian Zhang, Zhonggui He, Shenwu Zhang, Cong Luo	14
15	Self-crosslinking hyaluronic acid hydrogel as an enteroprotective agent for the treatment of inflammatory bowel disease 2024 ·International Journal of Biological Macromolecules ·(unknown), Dandan Song, Ruilong Ma, Mo Li, Bingyang Liu, Zhonggui He, Qiang Fu	10
16	Rational design of tumor-selective prodrug nanoassemblies: Greatly improving the in vivo fate and tolerability of high-toxic cabazitaxel 2023 ·Chemical Engineering Journal ·(unknown), Yu Zhang, (unknown), Danping Wang, Shiyi Zuo, (unknown), Zhonggui He, Qiming Kan, Xiaohong Liu, Bingjun Sun, Jin Sun	13
17	Dynamic immuno-nanomedicines in oncology 2023 ·Journal of Controlled Release ·Hao Ling, Qinyi Zhang, Qiuhua Luo, Defang Ouyang, Zhonggui He, (unknown), Mengchi Sun	0
18	Ligand-free high loading capacity ursolic acid self-carried nanovesicles enable hepatocyte targeting via absorbing apolipoproteins 2023 ·International Journal of Pharmaceutics ·(unknown), Wenwen Fan, (unknown), (unknown), Hongzhuo Liu, Zhonggui He, Yongjun Wang	6
19	Self-adaptive nanoassembly enabling turn-on hypoxia illumination and periphery/center closed-loop tumor eradication 2023 ·Cell Reports Medicine ·Ziyue Wang, Shenwu Zhang, Zhiqiang Kong, Songhao Li, Jin Sun, Ying Zheng, Zhonggui He, Hao Ye, Cong Luo	24
20	In situ self-assembled nanomedicines for cancer treatment 2023 ·Chemical Engineering Journal ·Xinxin Sun, Xiaohong Yang, Yao Chen, Jin Sun, Zhonggui He, Shenwu Zhang, Cong Luo	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact